Cholangiocarcinoma patients with FGFR2 fusions/rearrangements but primary refractory to pemigatinib: the real challenge?

Saved in:
Bibliographic Details
Published inESMO open Vol. 9; no. 10; p. 103936
Main Authors Rizzo, A., Ricci, A.D., Brandi, G.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2024
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2024.103936